Association of CDC25 phosphatase family polymorphisms with the efficacy/toxicity of platinum-based chemotherapy in Chinese advanced NSCLC patients | |
Cai, Weijing; Chen, Chang; Li, Xinzheng; Shi, Jinyun; Sun, Qian; Liu, Di; Sun, Yifeng; Hou, Likun; Zhao, Xueying; Gu, Shaohua | |
刊名 | FUTURE ONCOLOGY
![]() |
2014 | |
卷号 | 10期号:7 |
关键词 | CDC25 family chemotherapy lung cancer platinum single nucleotide polymorphism |
ISSN号 | 1479-6694 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4877483 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Cai, Weijing,Chen, Chang,Li, Xinzheng,et al. Association of CDC25 phosphatase family polymorphisms with the efficacy/toxicity of platinum-based chemotherapy in Chinese advanced NSCLC patients[J]. FUTURE ONCOLOGY,2014,10(7). |
APA | Cai, Weijing.,Chen, Chang.,Li, Xinzheng.,Shi, Jinyun.,Sun, Qian.,...&Qian, Ji.(2014).Association of CDC25 phosphatase family polymorphisms with the efficacy/toxicity of platinum-based chemotherapy in Chinese advanced NSCLC patients.FUTURE ONCOLOGY,10(7). |
MLA | Cai, Weijing,et al."Association of CDC25 phosphatase family polymorphisms with the efficacy/toxicity of platinum-based chemotherapy in Chinese advanced NSCLC patients".FUTURE ONCOLOGY 10.7(2014). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论